1. Recombinant Proteins
  2. Receptor Proteins
  3. G-Protein-Coupled Receptors (GPCRs)
  4. Cannabinoid Receptor

Cannabinoid receptors are currently classified into three groups: central (CB1), peripheral (CB2) and GPR55, all of which are G-protein-coupled. CB1 receptors are primarily located at central and peripheral nerve terminals. CB2 receptors are predominantly expressed in non-neuronal tissues, particularly immune cells, where they modulate cytokine release and cell migration. Recent reports have suggested that CB2 receptors may also be expressed in the CNS. GPR55 receptors are non-CB1/CB2 receptors that exhibit affinity for endogenous, plant and synthetic cannabinoids. Endogenous ligands for cannabinoid receptors have been discovered, including anandamide and 2-arachidonylglycerol.

Cat. No. Product Name / Synonyms Species Source
  • HY-P700636
    CNR2 Protein-VLP, Human (HEK293)

    CNR2; cannabinoid receptor 2 (macrophage); cannabinoid receptor 2; CB2

    Human HEK293
    CNR2 Protein-VLP, Human (HEK293) is recommended for animal immunization, ELISA. It is not recommended for receptor-ligand interaction detection and SPR/BLI assay since there are other irrelevant membrane proteins of the host on the VLP envelope, and the receptor-ligand interaction will have strong background interference. High requirements for chips and experimental protocols are needed for SPR/BLI assays.
  • HY-P700408
    CNR1 Protein-VLP, Human (HEK293, His)

    cannabinoid receptor 1 (brain); CNR; cannabinoid receptor 1; CANN6; CB R; CB1; CB1A; CB1K5; central cannabinoid receptor; CB-R; CB1R;

    Human HEK293
    CNR1 Protein-VLP, Human (HEK293, His) is recommended for animal immunization, ELISA. It is not recommended for receptor-ligand interaction detection and SPR/BLI assay since there are other irrelevant membrane proteins of the host on the VLP envelope, and the receptor-ligand interaction will have strong background interference. High requirements for chips and experimental protocols are needed for SPR/BLI assays.
  • HY-P702254
    CNR1 Protein, Rat (Cell-Free, His)

    Cannabinoid receptor 1; Brain-type cannabinoid receptor; CB-R; CB1

    Rat E. coli Cell-free
    The CNR1 protein is a G-protein-coupled receptor for cannabinoids, including cannabinoids and endocannabinoids such as 2-AG, which mediates diverse effects on food intake, memory, and pain. It regulates mitochondrial respiration and inhibits leptin-induced ROS formation. CNR1 Protein, Rat (Cell-Free, His) is the recombinant rat-derived CNR1 protein, expressed by E. coli Cell-free , with N-10*His labeled tag. The total length of CNR1 Protein, Rat (Cell-Free, His) is 473 a.a., with molecular weight of 58.9 kDa.
  • HY-P702255
    CNR2 Protein, Human (Cell-Free, His)

    Cannabinoid receptor 2; CX5; CB-2; CB2

    Human E. coli Cell-free
    CNR2 Protein-VLP, a heterotrimeric G protein-coupled receptor, crucially inhibits adenylate cyclase, mediating functions in inflammatory responses, nociceptive transmission, and bone homeostasis. Its modulation of cellular signaling underscores its significance in physiological processes, positioning CNR2 Protein-VLP as a key regulator in inflammatory, sensory mechanisms, and bone equilibrium. CNR2 Protein, Human (Cell-Free, His) is the recombinant human-derived CNR2 protein, expressed by E. coli Cell-free , with N-10*His labeled tag. The total length of CNR2 Protein, Human (Cell-Free, His) is 360 a.a., with molecular weight of 42.5 kDa.
Cat. No. Product Name Effect Purity